Labcorp Holdings
Labcorp Holdings Inc. is a United States life sciences company that provides comprehensive clinical laboratory services and diagnostic solutions worldwide. The company offers routine blood testing, specialized anatomic pathology, genomic profiling, companion diagnostics, and clinical trial laboratory services. Its operations utilize a national network of patient service centers, automated central testing laboratories, and specialized reference facilities. Revenue is primarily generated from fee-for-service diagnostic test execution billed to commercial health insurers, government programs, hospitals, and pharmaceutical sponsors. Key end markets encompass healthcare providers, hospital systems, biotechnology companies, and individual patients across the United States and international markets. Labcorp holds a market-leading position as one of the largest independent clinical laboratory networks globally. The enterprise is headquartered in Burlington, North Carolina, and its common stock is traded on the New York Stock Exchange under the ticker symbol LH.
35 of the funds FundTelligence covers report a position in Labcorp Holdings.
- Legal name
- Labcorp Holdings Inc.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 35
Funds holding Labcorp Holdings
- Nordea Globale Stabile Aktier - Etisk tilvalg — Nordea Funds · 4.04 % (full portfolio disclosed, July 2026)
- Nordea Global Stable Equity Fund - Unhedged — Nordea Funds · 3.2 % (full portfolio disclosed, July 2026)
- Nordea Stabile Aktier — Nordea Funds · 3.18 % (full portfolio disclosed, July 2026)
- Nordea Globale Stabile Aktier — Nordea Funds · 3.18 % (full portfolio disclosed, July 2026)
- Nordea Global Stable Equity Fund — Nordea Funds · 3.17 % (full portfolio disclosed, July 2026)
- Nordea Stabile Aksjer Global — Nordea Funds · 3.17 % (full portfolio disclosed, July 2026)
- Handelsbanken Global Utbytte — Handelsbanken · 1.41 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Högutdelande Criteria — Handelsbanken · 1.41 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 35 funds holding it.